Specify a stock or a cryptocurrency in the search bar to get a summary
XOMA Corp
XOMAXOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California. Address: 2200 Powell Street, EmeryVille, CA, United States, 94608
Analytics
WallStreet Target Price
86 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures XOMA
Dividend Analytics XOMA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History XOMA
Stock Valuation XOMA
Financials XOMA
Results | 2019 | Dynamics |